WO2013052424A3 - Compositions for enhancing nail health - Google Patents
Compositions for enhancing nail health Download PDFInfo
- Publication number
- WO2013052424A3 WO2013052424A3 PCT/US2012/058333 US2012058333W WO2013052424A3 WO 2013052424 A3 WO2013052424 A3 WO 2013052424A3 US 2012058333 W US2012058333 W US 2012058333W WO 2013052424 A3 WO2013052424 A3 WO 2013052424A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- health
- nail
- enhancing
- nail health
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020147011967A KR20140096048A (en) | 2011-10-05 | 2012-10-01 | Compositions for enhancing nail health |
AU2012318823A AU2012318823A1 (en) | 2011-10-05 | 2012-10-01 | Compositions for enhancing nail health |
BR112014008172A BR112014008172A2 (en) | 2011-10-05 | 2012-10-01 | nail health enhancing compositions |
EP12775399.4A EP2763649A2 (en) | 2011-10-05 | 2012-10-01 | Compositions for enhancing nail health |
CA2851346A CA2851346A1 (en) | 2011-10-05 | 2012-10-01 | Compositions for enhancing nail health |
JP2014534627A JP2014528447A (en) | 2011-10-05 | 2012-10-01 | Composition for improving nail health |
CN201280059691.1A CN103987370A (en) | 2011-10-05 | 2012-10-01 | Compositions for enhancing nail health |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161543758P | 2011-10-05 | 2011-10-05 | |
US61/543,758 | 2011-10-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013052424A2 WO2013052424A2 (en) | 2013-04-11 |
WO2013052424A3 true WO2013052424A3 (en) | 2013-11-14 |
Family
ID=47046873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/058333 WO2013052424A2 (en) | 2011-10-05 | 2012-10-01 | Compositions for enhancing nail health |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2763649A2 (en) |
JP (1) | JP2014528447A (en) |
KR (1) | KR20140096048A (en) |
CN (1) | CN103987370A (en) |
AR (1) | AR088234A1 (en) |
AU (1) | AU2012318823A1 (en) |
BR (1) | BR112014008172A2 (en) |
CA (1) | CA2851346A1 (en) |
TW (1) | TW201321025A (en) |
WO (1) | WO2013052424A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2855508B1 (en) | 2012-06-01 | 2018-02-14 | Allergan, Inc. | Cyclosporin a analogs |
TW201639873A (en) | 2015-01-08 | 2016-11-16 | 歐樂根公司 | Cyclosporin derivatives wherein the MEBMT sidechain has been cyclized |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060008432A1 (en) * | 2004-07-07 | 2006-01-12 | Sebastiano Scarampi | Gilsonite derived pharmaceutical delivery compositions and methods: nail applications |
WO2007008894A2 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
EP1958638A1 (en) * | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans to increase nail growth rate |
WO2010080913A1 (en) * | 2009-01-08 | 2010-07-15 | Allergan, Inc. | Cyclosporine compositions for enhancing nail growth |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907460A1 (en) | 1978-03-07 | 1979-09-13 | Sandoz Ag | NEW RESORBABLE GALENIC COMPOSITIONS |
US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
KR100820266B1 (en) | 1999-02-26 | 2008-04-08 | 더 유니버시티 오브 브리티쉬 콜롬비아 | TRPM-2 antisense therapy |
US6254860B1 (en) | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
-
2012
- 2012-10-01 BR BR112014008172A patent/BR112014008172A2/en not_active IP Right Cessation
- 2012-10-01 JP JP2014534627A patent/JP2014528447A/en active Pending
- 2012-10-01 WO PCT/US2012/058333 patent/WO2013052424A2/en active Application Filing
- 2012-10-01 KR KR1020147011967A patent/KR20140096048A/en not_active Application Discontinuation
- 2012-10-01 CN CN201280059691.1A patent/CN103987370A/en active Pending
- 2012-10-01 CA CA2851346A patent/CA2851346A1/en not_active Abandoned
- 2012-10-01 AU AU2012318823A patent/AU2012318823A1/en not_active Abandoned
- 2012-10-01 EP EP12775399.4A patent/EP2763649A2/en not_active Withdrawn
- 2012-10-04 AR ARP120103701A patent/AR088234A1/en not_active Application Discontinuation
- 2012-10-05 TW TW101137027A patent/TW201321025A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060008432A1 (en) * | 2004-07-07 | 2006-01-12 | Sebastiano Scarampi | Gilsonite derived pharmaceutical delivery compositions and methods: nail applications |
WO2007008894A2 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
EP1958638A1 (en) * | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans to increase nail growth rate |
WO2010080913A1 (en) * | 2009-01-08 | 2010-07-15 | Allergan, Inc. | Cyclosporine compositions for enhancing nail growth |
Non-Patent Citations (3)
Title |
---|
CANNAVÒ S P ET AL: "Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study", DERMATOLOGY, S. KARGER AG, CH, vol. 206, no. 2, 1 January 2003 (2003-01-01), pages 153 - 156, XP009134400, ISSN: 1018-8665 * |
JIARAVUTHISAN ET AL: "Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, C.V. MOSBY, ST. LOUIS, MO, US, vol. 57, no. 1, 1 July 2007 (2007-07-01), pages 1 - 27, XP022111711, ISSN: 0190-9622, DOI: 10.1016/J.JAAD.2005.07.073 * |
SYUTO TOMOKO ET AL: "Successful treatment of psoriatic nails with low-dose cyclosporine administration", EUROPEAN JOURNAL OF DERMATOLOGY, JOHN LIBBEY EUROTEXT, FR, vol. 17, no. 3, 1 May 2007 (2007-05-01), pages 248 - 249, XP002585865, ISSN: 1167-1122 * |
Also Published As
Publication number | Publication date |
---|---|
CN103987370A (en) | 2014-08-13 |
AU2012318823A1 (en) | 2014-04-24 |
TW201321025A (en) | 2013-06-01 |
KR20140096048A (en) | 2014-08-04 |
AR088234A1 (en) | 2014-05-21 |
EP2763649A2 (en) | 2014-08-13 |
JP2014528447A (en) | 2014-10-27 |
BR112014008172A2 (en) | 2017-04-18 |
CA2851346A1 (en) | 2013-04-11 |
WO2013052424A2 (en) | 2013-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY155235A (en) | Cyclosporine compositions for enhancing nail growth | |
MY163275A (en) | Ibat inhibitors for the treatment of liver diseases | |
WO2012088266A3 (en) | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 | |
CA2871471C (en) | Dna-pk inhibitors | |
MX2013006023A (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails. | |
EP2234621A4 (en) | Compositions and methods for treating diseases of the nail | |
WO2012075383A3 (en) | Bromodomain inhibitors and uses thereof | |
PH12015500301A1 (en) | A novel formulation of diclofenac | |
WO2012174487A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2012151512A3 (en) | Bromodomain inhibitors and uses thereof | |
EA201290919A1 (en) | INDASOLIC COMPOUNDS AND THEIR APPLICATION | |
WO2013184876A8 (en) | Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof | |
WO2009135006A3 (en) | Methods for preventing oxidative damage to hair and promote hair shine | |
EA201291357A1 (en) | TREATMENT METHODS USING TLR7 AND / OR TLR9 INHIBITORS | |
MX2011011233A (en) | A novel formulation of metaxalone. | |
MX351930B (en) | A novel formulation of indomethacin. | |
WO2013052380A3 (en) | Compositions for enhancing nail health | |
WO2009146079A3 (en) | Compositions and methods to control oomycete fungal pathogens | |
WO2012130820A3 (en) | Isopentyl esters for the use in cosmetic, dermatological, or pharmaceutical compositions | |
EA201171001A1 (en) | HERBAL PEPTIDES FOR VACCINE | |
WO2012012798A3 (en) | Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases | |
WO2013052424A3 (en) | Compositions for enhancing nail health | |
WO2012103282A3 (en) | Methods and compositions for treating alzheimer's disease | |
NZ708821A (en) | Lfa-1 inhibitor formulations | |
BR112014004737A2 (en) | Ambroxol Hydrochloride Compound Compound and Method of Preparation of Compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2014534627 Country of ref document: JP Kind code of ref document: A Ref document number: 2851346 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2012775399 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012775399 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2012318823 Country of ref document: AU Date of ref document: 20121001 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20147011967 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2014117113 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014008172 Country of ref document: BR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12775399 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 112014008172 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140404 |